Antibiotic-Induced Changes in the Intestinal Microbiota and Disease

Trends in Molecular Medicine

Volumn 22, Issue 6, 2016, Pages 458-478

  Becattini, Simone ^a   Taur, Ying ^a   Pamer, Eric G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Antibiotic resistance; Antibiotics; Disease; Gut microbiota; Immunity

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CONJUGATION; GENE MUTATION; GENETIC RESISTANCE; GENETIC TRANSDUCTION; GENETIC TRANSFORMATION; HOST RESISTANCE; HUMAN; INFECTION; INTESTINE FLORA; MICROBIAL COLONIZATION; MICROBIAL IMMUNITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; ANIMAL; BACTERIUM; CELL LINE; DRUG EFFECTS; GENETICS; IMMUNE SYSTEM; METABOLISM; MOUSE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CELL LINE; DRUG RESISTANCE, BACTERIAL; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; MICE;

EID: 84969921123     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2016.04.003     Document Type: Review

References (151)

1. Qin J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
2. Walter J., Ley R. The human gut microbiome: ecology and recent evolutionary changes. Annu. Rev. Microbiol. 2011, 65:411-429.
3. Brestoff J.R., Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat. Immunol. 2013, 14:676-684.
4. Buffie C.G., Pamer E.G. Microbiota-mediated colonization resistance against intestinal pathogens. Nat. Rev. Immunol. 2013, 13:790-801.
5. Goyal M.S., et al. Feeding the brain and nurturing the mind: linking nutrition and the gut microbiota to brain development. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:14105-14112.
6. Marsland B.J., Salami O. Microbiome influences on allergy in mice and humans. Curr. Opin. Immunol. 2015, 36:94-100.
7. Caballero S., Pamer E.G. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu. Rev. Immunol. 2015, 33:227-256.
8. O'Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006, 7:688-693.
9. Sommer F., Backhed F. The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol. 2013, 11:227-238.
10. Kelly C.J., et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015, 17:662-671.
11. Reinhardt C., et al. Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature 2012, 483:627-631.
12. Luna R.A., Foster J.A. Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Curr. Opin. Biotechnol. 2015, 32:35-41.
13. Mayer E.A., et al. Gut/brain axis and the microbiota. J. Clin. Invest. 2015, 125:926-938.
14. Mu C., et al. Gut microbiota: the brain peacekeeper. Front. Microbiol. 2016, 7:345.
15. Collins S.M., et al. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 2012, 10:735-742.
16. Rakoff-Nahoum S., et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
17. Cash H.L., et al. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
18. Brandl K., et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455:804-807.
19. Kinnebrew M.A., et al. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J. Infect. Dis. 2010, 201:534-543.
20. + dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 2012, 36:276-287.
21. Yang Y., et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 2014, 510:152-156.
22. Clarke T.B., et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 2010, 16:228-231.
23. Deshmukh H.S., et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat. Med. 2014, 20:524-530.
24. Hill D.A., et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat. Med. 2012, 18:538-546.
25. Ichinohe T., et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5354-5359.
26. Abt M.C., et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012, 37:158-170.
27. Ganal S.C., et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012, 37:171-186.
28. Mazmanian S.K., et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
29. Ivanov I.I., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008, 4:337-349.
30. H17 cell differentiation. Nature 2008, 455:808-812.
31. Ivanov I.I., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
32. Gaboriau-Routhiau V., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
33. Sano T., et al. An IL-23R/IL-22 circuit regulates epithelial serum amyloid a to promote local effector Th17 responses. Cell 2015, 163:381-393.
34. Atarashi K., et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 2015, 163:367-380.
35. Mortha A., et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 2014, 343:1249288.
36. Atarashi K., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
37. Atarashi K., et al. Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature 2013, 500:232-236.
38. Arpaia N., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504:451-455.
39. Furusawa Y., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504:446-450.
40. Smith P.M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341:569-573.
41. Sun J., et al. Pancreatic beta-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 2015, 43:304-317.
42. Markle J.G., et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013, 339:1084-1088.
43. Fox H.S. Androgen treatment prevents diabetes in nonobese diabetic mice. J. Exp. Med. 1992, 175:1409-1412.
44. Roden A.C., et al. Augmentation of T cell levels and responses induced by androgen deprivation. J. Immunol. 2004, 173:6098-6108.
45. Kissick H.T., et al. Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:9887-9892.
46. Trompette A., et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 2014, 20:159-166.
47. Proietti M., et al. ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer's patches to promote host-microbiota mutualism. Immunity 2014, 41:789-801.
48. Oh J.Z., et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 2014, 41:478-492.
49. Wlodarska M., et al. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 2011, 79:1536-1545.
50. Wlodarska M., et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 2014, 156:1045-1059.
51. Fan D., et al. Activation of HIF-1alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat. Med. 2015, 21:808-814.
52. Fukuda S., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547.
53. van Nood E., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 2013, 368:407-415.
54. Buffie C.G., et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015, 517:205-208.
55. Hsiao A., et al. Members of the human gut microbiota involved in recovery from Vibrio cholerae infection. Nature 2014, 515:423-426.
56. Kommineni S., et al. Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature 2015, 526:719-722.
57. David L.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505:559-563.
58. Suez J., et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014, 514:181-186.
59. Zeevi D., et al. Personalized nutrition by prediction of glycemic responses. Cell 2015, 163:1079-1094.
60. Karlsson F.H., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013, 498:99-103.
61. Qin J., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
62. Forslund K., et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015, 528:262-266.
63. Lewis J.D., et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe. 2015, 18:489-500.
64. Turnbaugh P.J., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
65. Ridaura V.K., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013, 341:1241214.
66. Yoshimoto S., et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013, 499:97-101.
67. Belcheva A., et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 2014, 158:288-299.
68. Koeth R.A., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 2013, 19:576-585.
69. Wang Z., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63.
70. Tang W.H., et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 2013, 368:1575-1584.
71. Wang Z., et al. Non-lethal Inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 2015, 163:1585-1595.
72. Haiser H.J., et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 2013, 341:295-298.
73. Elinav E., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
74. Winter S.E., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013, 339:708-711.
75. Seo S.U., et al. Distinct commensals induce interleukin-1beta via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury. Immunity 2015, 42:744-755.
76. Ayres J.S., et al. Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat. Med. 2012, 18:799-806.
77. Pacheco A.R., et al. Fucose sensing regulates bacterial intestinal colonization. Nature 2012, 492:113-117.
78. Ng K.M., et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502:96-99.
79. Fonseca D.M., et al. Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity. Cell 2015, 163:354-366.
80. Horai R., et al. Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged Site. Immunity 2015, 43:343-353.
81. Jernberg C., et al. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007, 1:56-66.
82. Buffie C.G., et al. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect. Immun. 2012, 80:62-73.
83. Ubeda C., et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 2010, 120:4332-4341.
84. Lewis B.B., et al. Loss of microbiota-mediated colonization resistance to Clostridium difficile infection with oral vancomycin compared with metronidazole. J. Infect. Dis. 2015, 212:1656-1665.
85. Dominguez-Bello M.G., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11971-11975.
86. Dominguez-Bello M.G., et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat. Med. 2016, 22:250-253.
87. Kozyrskyj A.L., et al. Increased risk of childhood asthma from antibiotic use in early life. Chest 2007, 131:1753-1759.
88. Risnes K.R., et al. Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children. Am. J. Epidemiol. 2011, 173:310-318.
89. Korpela K., et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat. Commun. 2016, 7:10410.
90. Russell S.L., et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012, 13:440-447.
91. Cox L.M., et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014, 158:705-721.
92. Levy S.B., et al. High frequency of antimicrobial resistance in human fecal flora. Antimicrob. Agents Chemother. 1988, 32:1801-1806.
93. Sommer M.O., et al. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009, 325:1128-1131.
94. Santiago-Rodriguez T.M., et al. Gut microbiome of an 11th Century A.D. pre-Columbian Andean mummy. PloS ONE 2015, 10:e0138135.
95. D'Costa V.M., et al. Antibiotic resistance is ancient. Nature 2011, 477:457-461.
96. Bhullar K., et al. Antibiotic resistance is prevalent in an isolated cave microbiome. PloS ONE 2012, 7:e34953.
97. Modi S.R., et al. Antibiotics and the gut microbiota. J. Clin. Invest. 2014, 124:4212-4218.
98. Oldenburg M., et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 2012, 337:1111-1115.
99. Cullen T.W., et al. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation. Science 2015, 347:170-175.
100. Koch G., et al. Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competition. Cell 2014, 158:1060-1071.
101. Looft T., et al. In-feed antibiotic effects on the swine intestinal microbiome. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1691-1696.
102. Forsberg K.J., et al. The shared antibiotic resistome of soil bacteria and human pathogens. Science 2012, 337:1107-1111.
103. Hu Y., et al. The abundance of antibiotic resistance genes in human guts has correlation to the consumption of antibiotics in animal. Gut Microbes 2014, 5:245-249.
104. Field W., Hershberg R. Alarmingly high segregation frequencies of quinolone resistance alleles within human and animal microbiomes are not explained by direct clinical antibiotic exposure. Genome. Biol. Evol. 2015, 7:1743-1757.
105. Moore A.M., et al. Gut resistome development in healthy twin pairs in the first year of life. Microbiome 2015, 3:27.
106. Lu N., et al. DNA microarray analysis reveals that antibiotic resistance-gene diversity in human gut microbiota is age related. Sci. Rep. 2014, 4:4302.
107. Toprak E., et al. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat. Genet. 2012, 44:101-105.
108. Lee H.H., et al. Bacterial charity work leads to population-wide resistance. Nature 2010, 467:82-85.
109. Kelsic E.D., et al. Counteraction of antibiotic production and degradation stabilizes microbial communities. Nature 2015, 521:516-519.
110. Costello E.K., et al. The application of ecological theory toward an understanding of the human microbiome. Science 2012, 336:1255-1262.
111. Hehemann J.H., et al. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010, 464:908-912.
112. Schloissnig S., et al. Genomic variation landscape of the human gut microbiome. Nature 2013, 493:45-50.
113. Beaber J.W., et al. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 2004, 427:72-74.
114. Modi S.R., et al. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 2013, 499:219-222.
115. Slager J., et al. Antibiotic-induced replication stress triggers bacterial competence by increasing gene dosage near the origin. Cell 2014, 157:395-406.
116. Laxminarayan R. Antibiotic effectiveness: balancing conservation against innovation. Science 2014, 345:1299-1301.
117. Kelly C.R., et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am. J. Gastroenterol. 2014, 109:1065-1071.
118. Lawley T.D., et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012, 8:e1002995.
119. Reeves A.E., et al. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect. Immun. 2012, 80:3786-3794.
120. Ubeda C., et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect. Immun. 2013, 81:965-973.
121. Abt M.C., et al. TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus. Sci. Transl. Med. 2016, 8:327ra325.
122. Donia M.S., et al. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 2014, 158:1402-1414.
123. Howe J.A., et al. Selective small-molecule inhibition of an RNA structural element. Nature 2015, 526:672-677.
124. Rea M.C., et al. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(Suppl 1):4639-4644.
125. Gebhart D., et al. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity. MBio 2015, 6.
126. Lehar S.M., et al. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature 2015, 527:323-328.
127. Bikard D., et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat. Biotechnol. 2014, 32:1146-1150.
128. Citorik R.J., et al. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 2014, 32:1141-1145.
129. Rajilic-Stojanovic M., de Vos W.M. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol. Rev. 2014, 38:996-1047.
130. Ley R.E., et al. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11070-11075.
131. Nguyen T.L., et al. How informative is the mouse for human gut microbiota research?. Dis. Model. Mech. 2015, 8:1-16.
132. Xiao L., et al. A catalog of the mouse gut metagenome. Nat. Biotechnol. 2015, 33:1103-1108.
133. Seedorf H., et al. Bacteria from diverse habitats colonize and compete in the mouse gut. Cell 2014, 159:253-266.
134. Blanton L.V., et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science 2016, 351.
135. Kau A.L., et al. Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy. Sci. Transl. Med. 2015, 7:276ra224.
136. Schluter J., Foster K.R. The evolution of mutualism in gut microbiota via host epithelial selection. PLoS Biol. 2012, 10:e1001424.
137. Pickard J.M., et al. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 2014, 514:638-641.
138. Hand T.W., et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 2012, 337:1553-1556.
139. Johansson M.E., et al. Normalization of host intestinal mucus layers requires long-term microbial colonization. Cell Host Microbe. 2015, 18:582-592.
140. hi cells. Nature 2013, 494:116-120.
141. + T-cell responses to intestinal commensal bacteria. Nature 2013, 498:113-117.
142. + T cells. Science 2015, 348:1031-1035.
143. Fanning S., et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:2108-2113.
144. Iida N., et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013, 342:967-970.
145. Viaud S., et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013, 342:971-976.
146. Sivan A., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 2015, 350:1084-1089.
147. Vetizou M., et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 2015, 350:1079-1084.
148. Dubin K., et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat. Commun. 2016, 7:10391.
149. Chang Q., et al. Antibiotics in agriculture and the risk to human health: how worried should we be?. Evol. Appl. 2015, 8:240-247.
150. Meek R.W., et al. Nonmedical uses of antibiotics: time to restrict their use?. PLoS Biol. 2015, 13:e1002266.
151. Kennedy D. Time to deal with antibiotics. Science 2013, 342:777.